Revenue segments as reported by the company.

Life Sciences and Applied Markets Group

Diagnostics and Genomics Group

Agilent CrossLab Group

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Selling, general and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Agilent Technologies

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Agilent Technologies posts strong Q1 earnings, eyes PFAS testing and CRISPR expansion

Agilent Technologies delivered robust Q1 results, raised full-year guidance, and remains confident in its growth drivers. Despite challenges in the genomics market and uncertainties ahead, the company is strategically positioned to capitalize on opportunities and drive continued success.

Agilent reports strong Q2 earnings but revises down second-half forecast

Agilent Technologies delivered strong Q2 results but revised down second-half forecasts due to economic uncertainties. The company remains focused on driving margin expansion, cost efficiencies, and customer service excellence. Challenges from macroeconomic factors and market dynamics are being addressed with a strategic outlook for long-term growth.

Agilent Technologies faces China revenue challenges but eyes growth opportunities

Agilent Technologies faces revenue challenges in China but sees growth opportunities in companion diagnostics and liquid biopsy markets. The company remains confident in its ability to drive earnings growth despite recent setbacks.

Agilent reports mixed Q4 results, eyes steady recovery in 2024

Agilent Technologies reported mixed Q4 results with revenue decline but exceeded EPS guidance. While facing challenges in China and certain segments, the company anticipates slow but steady recovery for FY 2024. Agilent is focusing on cost-saving measures, pricing trends, and investments in growth areas like genomics and environmental solutions.

Agilent reports Q1 revenue decline, eyes global growth opportunities

Agilent Technologies' Q1 performance showed revenue decline but with strengths in certain segments like ACG and consumables. Challenges include revenue declines in DGG and LSAG impacting margins. Opportunities lie in global growth prospects and potential market surprises.

Agilent Technologies faces revenue decline but eyes growth opportunities ahead

Agilent Technologies navigated a challenging market in Q2 2024 with revenue declines across all end markets. The company remains focused on customer-centric strategies, cost optimization, and growth investments while addressing visibility challenges and exploring opportunities in high-growth segments.

Agilent reports Q3 earnings beat, eyes growth through acquisitions

Agilent Technologies delivered a solid performance in Q3 2024, exceeding earnings per share guidance and raising revenue and EPS midpoint guidance.
While facing revenue decline, the company's strategic investments and acquisitions signal a focus on growth and innovation.
Challenges include market dynamics and integration risks, but opportunities exist in leveraging digital initiatives and financial strength for future growth.

Agilent Technologies reports robust Q4 performance and outlines growth strategies

Agilent Technologies' Q4 2024 earnings call highlighted strong financial performance, strategic acquisitions, and a focus on margin expansion for sustainable growth.
Despite regional challenges and market uncertainties, the company remains optimistic about future prospects and is committed to driving EPS growth.
With a new market-focused approach and ongoing transformation initiatives, Agilent is well-positioned to capitalize on opportunities and navigate potential challenges in FY 2025.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SANTA CLARA, Calif.--(BUSINESS WIRE)--For the sixth consecutive year, Agilent Technologies (NYSE: A) is ranked among the top 20 in Barron's list of America's 100 Most Sustainable Companies. The ranking is based on the performance of the 1,000 largest publicly held companies on a variety of ESG (Environmental, Social and Governance) measures, including workplace diversity, greenhouse-gas emissions and waste.

Agilent Again Named One of Barron's 100 Most Sustainable Companies

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion, an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. The ExD cell is a compact device for mass spectrometers that enables biological researchers to develop biotherapeutic products more quickly to treat disease.

Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development

American Tower

Barnes Group

Bank of America

Citigroup

Crown Castle International

Credit Suisse

Equinix

JPMorgan Chase & Co

Realty Income Corp

Prologis

Public Storage

SBA Communications

Simon Property Group

Vanguard Real Estate ETF

Yesterday, Chairman Powell signaled more rate hikes are required to tame this stubborn spell of inflation. The entire yield curve has moved up, and notably, during FY 2023. On December 13, 2022, Howard Marks penned a compelling piece - Sea Change. His chief argument is the era of cheap money was the driver of the robust equity returns.

If Howard Marks' Sea Change Memo Is Correct, REITs And High Yield Stocks Look Unattractive

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia's Concentriq® Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.

Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Bob McMahon will participate in a Q&A session at the Barclays Global Healthcare Conference in Miami Beach, Florida, on March 15 at 3:05 p.m. EST. Participants can join the webcast by accessing the link from the Agilent Investor Relations website. A replay of the session will also be available for 90 days after the event. About Agilent Technologies Agilent Technologies Inc.

Agilent to Present at Barclays Global Healthcare Conference

Agilent (A) possesses solid growth attributes, which could help it handily outperform the market.

3 Reasons Growth Investors Will Love Agilent (A)

The heavy selling pressure might have exhausted for Agilent (A) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Agilent (A) Loses -11.54% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Agilent Technologies' (A) first-quarter fiscal 2023 results reflect strength across pharma and applied markets.

Agilent's (A) Q1 Earnings & Revenues Beat Estimates, Rise Y/Y

Agilent (A) delivered earnings and revenue surprises of 4.58% and 3.78%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

Agilent Technologies (A) Surpasses Q1 Earnings and Revenue Estimates

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a core(1) basis. First-quarter GAAP net income was $352 million, or $1.19 per share. This compares with $283 million, or 93 cents per share, in the first quarter of fiscal year 2022. Non-GAAP(2) net income was $406 million, or $1.

Agilent Reports First-Quarter Fiscal Year 2023 Financial Results

Apple

AGCO

Coterra Energy

Eaton

Expeditors International of Washington

Hershey

J.B. Hunt Transport Services

KLA-Tencor

Lamb Weston Hlds

Microsoft

Parker-Hannifin

Reliance Steel & Aluminum

Steel Dynamics

Tractor Supply

Visa

Watsco

We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.

Earn Double-Digit Income With Options (March 2023)

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of an on-deck thermal cycler (ODTC) that integrates with the Agilent Bravo NGS automated liquid handling platform. The optional ODTC accessory enables the Bravo platform to provide thermal cycling as part of an automated workflow for next-generation sequencing (NGS), end-point PCR, and cell-based applications.

Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler

Hewlett Packard

Sterling Construction

Investors will certainly want to keep Agilent Technologies (A) and Sterling Infrastructure (STRL) on their radars as there could still be plenty of upside and opportunity in these innovative companies.

Time to Buy These Innovative Stocks Before Earnings?

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek BioSpa 8 Automated Incubator.

Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that it will highlight a suite of automated laboratory workflow solutions at the SLAS2023 International Conference and Exhibition held February 25 through March 1 in San Diego. Agilent is also honored to receive an SLAS Lab of the Future designation, signifying going beyond automated instrumentation and bringing complete integrated automated workflow solutions to the lab.

Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions

FREDERICK, Colo.--(BUSINESS WIRE)--Leaders from Agilent Technologies Inc. (NYSE: A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent's $725 million investment to double manufacturing capacity of therapeutic nucleic acids in Frederick, Colorado. The investment will create more than 160 life science jobs in the Frederick area; contribute to the state's rapidly growing biotechnology ecosystem; and increase U.S.

Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick

Caterpillar

Chevron

The stock market bloodbath is finally starting to subside.  And, with inflation finally cooling off, it is time to look for some of the top most overlooked stocks.

The 3 Most Overlooked Stocks to Buy Now

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of new NovoExpress software that introduces integrated compliance tools for NovoCyte flow cytometer systems. The compliance-enabling features enable users to meet regulatory requirements defined in FDA 21 CFR Part 11 and Annex 11. There is immense pressure on pharmaceutical and biopharmaceutical manufacturers to demonstrate compliance with regulatory requirements such as 21 CFR part 11.

Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

Archer-Daniels-Midland Company

Cardinal Health

Deere & Company

Republic Services

Archer-Daniels (ADM), Agilent Technologies (A), Republic Services (RSG), Deere & Company (DE) and Cardinal Health (CAH) seem solid picks for this month.

5 Top Dividend Growth Stocks to Buy in the Month of Love

SANTA CLARA, Calif.--( BUSINESS WIRE )--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2023 after the stock market closes on Tuesday, Feb. 28. The company will host a live webcast of its earnings conference call in listen-only mode on the same day. Below are details for the webcast:

Agilent to Announce First-Quarter Fiscal Year 2023 Financial Results Feb. 28

Expedia

Kroger

Lyft

Philip Morris

As brokers have a deeper insight into stocks, one must follow rating upgrades for solid returns. We pick Philip Morris (PM), Kroger (KR), Expedia (EXPE), Lyft (LYFT) and Agilent (A) as these witness rating upgrades.

5 Stocks With Upgraded Broker Ratings for Solid Returns in 2023

Piedmont Lithium

Corporate Update Quarterly Activities and Cash Flow Report for the quarter ended 31 December 2022 Highlights SYDNEY, AUSTRALIA / ACCESSWIRE / January 30, 2023 / The Board of Atlantic Lithium Limited ("Atlantic Lithium" or the "Company"), the funded African-focussed lithium exploration and development company targeting to deliver Ghana's first lithium mine, is pleased to present its Quarterly Activities Report for the period ended 31 December 2022. During the quarter, Atlantic Lithium successfully lodged the Mining License Application for the Ewoyaa Lithium Project ("Ewoyaa" or the "Project"), appointed a new Chief Operating Officer, awarded the Front-End Engineering Design (FEED) contract to Primero Group, appointed a Project Manager and continued to focus on advancing studies with further drill results received and highest intersections to date in drilling at the Project, located in Ghana, West Africa.

Atlantic Lithium Limited Announces Quarterly Activities and Cash Flow Report Dec 2022

Kinder Morgan

Stock buybacks, also known as share repurchase programs, are a common strategy we see implemented by companies to boost shareholder value. With these companies buying, it raises a valid question: Are shares undervalued?

These 3 Companies Can't Get Enough of Their Own Stock

In a month marred by job cuts seemingly everywhere in Silicon Valley, Agilent Technologies Inc. A, +2.01% Chief Executive Mike McMullen pledged no layoffs this year in a meeting with employees last week. Shares of Agilent are up 15% over the last 12 months.

Agilent CEO vows no layoffs in 2023

Quest Diagnostics

SANTA CLARA, Calif.--( BUSINESS WIRE )--Agilent Technologies Inc. (NYSE: A) today announced an agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The alliance will enable providers and patients throughout the United States to access the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test. Healthcare providers can order the test beginning today.

News for Agilent Technologies Stock (A)